Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how quickly you can move air in and out and how efficiently your lungs transfer ...
Good breathing is at the heart of good health. When asthma or shortness of breath appears, a person might be sent for pulmonary function tests. Arlene Dunlap of Piscataway, N.J. knows those tests well ...
Researchers used 6MWD to assess the association between physical function and the effectiveness of ART and anti-tubercular therapy in patients with HIV/TB co-infection. In patients with TB/HIV, higher ...
Slower oxygen recovery after a 6-minute walk test may predict poorer lung function and a higher risk for disease progression in patients with fibrotic interstitial lung disease.
Please provide your email address to receive an email when new articles are posted on . Full pulmonary function tests contribute useful diagnostic information for evaluating patients with ...
A phlegmy cough and shortness of breath are possible warning signs of chronic obstructive pulmonary disease (COPD). Keeping track of your symptoms and knowing your risk factors can help you test ...
Please provide your email address to receive an email when new articles are posted on . In a new study, removing “race correction” from the interpretation of pulmonary function test results signaled ...
Q:I have been wheezing on and off lately and had a lung-function test at my primary-care doctor's office. It showed my lung function was fine. Does that mean I don't have asthma? I had asthma when I ...
NEW YORK (AP) — Racial bias built into a common medical test for lung function is likely leading to fewer Black patients getting care for breathing problems, a study published Thursday suggests. As ...
Removing a patient’s race from an equation used to assess lung function — a change called for by health equity advocates — would mean that the lung disease of nearly half a million Black Americans ...
News-Medical.Net on MSN
Prospera™ featured in landmark interventional study advancing lung transplant care
Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the publication of a new prospective clinical trial in Transplantation Direct . The study, which was conducted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results